On November 11, 2021 Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for cancer, reported that the company will participate in the Society for Immunotherapy of Cancer (SITC) (Free SITC Whitepaper) Annual Meeting, November 12-14, including online poster presentations and online industry sponsored symposium (Press release, Personalis, NOV 11, 2021, View Source [SID1234595290]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The company will showcase the Personalis NeXT Platform which enables comprehensive analysis of both a tumor and its immune microenvironment from a single sample. The NeXT Platform can be used to investigate the key tumor and immune-related areas of cancer biology, consolidating multiple oncology biomarker assays into one and maximizing the biological information that can be generated from a precious tumor specimen.
Following is a list of abstracts that will be presented online at the meeting.
Scientific Poster Presentations
Poster Number & Category
Title & Presenter
Day & Time
19
Biomarkers, Immune Monitoring, and Novel Technologies
Exome-scale liquid biopsy characterization of emerging immune resistance mechanisms in treatment-resistant GIST
Presenter: Charles W. Abbott, PhD
NOV 12 -14 | Online
20
Biomarkers, Immune Monitoring, and Novel Technologies
Tumor-informed liquid biopsy monitoring of evolving therapeutic resistance mechanisms in head and neck squamous cell carcinoma patients receiving anti-PD-1 therapy
Presenter: Charles W. Abbott, Ph.D.
NOV 12 -14 | Online
75
Biomarkers, Immune Monitoring, and Novel Technologies
Comprehensive profiling of the tumor-immune microenvironment using an augmented transcriptome
Presenter: Eric Levy, PhD
NOV 12 -14 | Online
79
Biomarkers, Immune Monitoring, and Novel Technologies
Extensively validated HLA LOH algorithm demonstrates an association between HLA LOH and genomic instability
Presenter: Rachel M. Pyke, PhD
NOV 12 -14 | Online
Following are details of an industry-sponsored symposium which will be presented online at the meeting.
Industry Sponsor Symposium
Presentation Category
Title & Presenter
Day & Time
Sponsored Symposia
Leveraging comprehensive genomic data for diagnostic capabilities and composite biomarker discovery in immunotherapy
Presenter: Erin N. Newburn, PhD
NOV 12 | 1:30 – 2:00 PM EST
Personalis will also be exhibiting during the online portion of conference. Representatives will be available online to answer questions about the company’s cancer immunogenomics services.